New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
20:25 EDTAER, AER, LOJN, LOJN, RCPT, RCPT, TOUR, TOUR, OCIP, OCIP, CST, CST, FLO, FLO, KATE, KATE, VAL, VAL, TW, TW, CVG, CVGNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include AerCap Holdings (AER), consensus 77c; Towers Watson (TW), consensus $1.25; Valspar (VAL), consensus $1.13; Kate Spade (KATE), consensus 0c; Flowers Foods (FLO), consensus 24c; CST Brands (CST), consensus 49c; OCI Partners (OCIP), consensus 64c; Tuniu (TOUR), consensus (21c); Receptos (RCPT), consensus (85c); LoJack (LOJN), one estimate 4c; Convergys (CVG), consensus 32c.
News For AER;TW;VAL;KATE;FLO;CST;OCIP;TOUR;RCPT;LOJN;CVG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 1, 2015
10:00 EDTTWOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Autoliv (ALV) downgraded to Underperform from Outperform at Exane BNP Paribas... Baxter (BAX) downgraded to Neutral from Outperform at Credit Suisse... Carter's (CRI) downgraded to Buy from Conviction Buy at Goldman... Fiat Chrysler (FCAU) downgraded to Neutral from Outperform at Exane BNP Paribas... H&E Equipment (HEES) downgraded to Sector Weight from Overweight at KeyBanc... L'Oreal (LRLCY) downgraded to Sell from Neutral at Citi... Marchex (MCHX) downgraded to Equal Weight from Overweight at Stephens... NASDAQ (NDAQ) downgraded to Market Perform from Outperform at Keefe Bruyette... Starbucks (SBUX) downgraded to Buy from Conviction Buy at Goldman... Towers Watson (TW) downgraded to Hold from Buy at Deutsche Bank... Tuesday Morning (TUES) downgraded to Accumulate from Buy at Johnson Rice... United Rentals (URI) downgraded to Sector Weight from Overweight at KeyBanc.
08:30 EDTKATEKate Spade valuation attractive, says BofA/Merrill
Subscribe for More Information
08:02 EDTTWTowers Watson should be bought on weakness, says Stifel
After Towers Watson (TW) agreed to merge with Willis Group (WSH), Stifel says that the decline in Towers' stock was overdone. The firm says that some investors are worried that the move signals that Towers Watson is worried about its exchange business. However, the firm believes that Towers Watson made the deal in order to acquire the distribution channel in the hottest part of the exchange business. Stifel thinks that the combined company can generate $10+ in EPS by 2018. It trimmed its price target on Towers Watson to $143 from $148 but keeps a Buy rating on the shares.
07:33 EDTTWTowers Watson selloff yesterday a buying opportunity, says Jefferies
Subscribe for More Information
06:55 EDTTWTowers Watson downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank downgraded Towers Watson (TW) to Hold following the company's planned merger with Willis Group (WSH). Deutsche views shares as fairly valued at current levels.
June 30, 2015
09:26 EDTTW, RCPTOn The Fly: Pre-market Movers
Subscribe for More Information
09:13 EDTKATECowen lowers handbag estimates, calls Kate Spade favorite name in space
Subscribe for More Information
05:33 EDTAERAerCap adds first Airbus A350XWB to aircraft fleet
AerCap (AER) took delivery of its first Airbus (EADSY) A350 XWB during a ceremony at the Airbus Delivery Centre in Toulouse. AerCap immediately handed the aircraft over to Vietnam Airlines on a long-term lease, making the airline the world's second operator of the A350 XWB.
05:19 EDTTWWillis Group holder ValueAct Capital agrees to vote its shares in favor of deal
Subscribe for More Information
05:18 EDTTWTowers Watson holders will receive 2.65 shares of Willis per share of TW
Subscribe for More Information
05:15 EDTTWTowers Watson CEO McCann to be CEO of new company Willis CEO to be Deputy CEO
Upon closing of the transaction, James McCann will become chairman, John Haley, chairman and CEO of Towers Watson (TW), will be CEO and Dominic Casserley, CEO of Williw Group (WSH), will be president and Deputy CEO. The new company’s board will consist of 12 directors total – six nominated by Willis and six by Towers Watson, including Towers Watson’s and Willis’ current CEOs. Additionally, Roger Millay will be CFO.
05:11 EDTTWWillis Group, Towers Watson to merge in transaction valued at $18B
Subscribe for More Information
05:08 EDTTWWillis Group, Towers Watson to merge in transaction valued at $18B
Subscribe for More Information
June 26, 2015
10:14 EDTRCPTOptions with decreasing implied volatility
Subscribe for More Information
June 22, 2015
07:44 EDTCSTCST Brands deals raise partnership value, says Wells Fargo
Subscribe for More Information
June 19, 2015
10:27 EDTRCPTReceptos CFO says company has not canceled any events, Bloomberg reports
Subscribe for More Information
10:27 EDTRCPTReceptos calls active amid renewed takeover speculation
Subscribe for More Information
10:11 EDTRCPTReceptos did not cancel any conferences, says Evercore ISI
Evercore ISI commented on speculation that Receptos canceled out of conference and said the company has not canceled out of any brokers conferences.
10:08 EDTRCPTReceptos jumps amid continued takeover speculation
Speculation of a takeover is again taking shares of Receptos (RCPT) higher. The biopharma company, which has been frequently mentioned as a buyout candidate in blogs and analyst notes, is rumored to have canceled all of its conference appearances. The conference cancelations are unconfirmed, however, and it’s not even clear if the company had any scheduled appearances. Further, while KYTHERA (KYTH) was recently acquired after canceling an appearance at a conference, such moves by companies often do not mean acquisition talks are underway. Shares of Receptos are well of their highs but remain up $1.94 to $189.06 in early trading.
09:49 EDTRCPTRumor: Receptos active amid renewed takeover speculation
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use